Press Releases
Search
-
27 Feb 2019
bioMérieux – 2018 Financial Results
Organic sales growth of 9.9% for full-year 2018: €2,421 million in sales Up 5.8% as reported Solid fourth-quarter performance, with organic growth of more than 10% Improvement in contributive operatin...
-
07 Feb 2019
bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing
bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition of Invisible Sentinel Inc. This company, based in Philadelphia (PA) d...
-
19 Dec 2018
bioMérieux receives FDA clearance for BPA and BPN culture bottles used with BACT/ALERT® VIRTUO® for quality control testing of platelets
bioMérieux, a world leader in the field of in vitro diagnostics, announces that its culture bottles BACT/ALERT® BPA and BPN have received 510(k) clearance from the U.S. Food and Drug Administration (F...
-
13 Nov 2018
bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with FDA clearance and CE Marking
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the Food and Drug Administration (FDA) 510(k) clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel and the CE-Mark of t...
-
09 Nov 2018
bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the acquisition of a majority holding in Suzhou Hybiome Biomedical Engineering Co.Ltd. This announcement follows the ac...
-
18 Oct 2018
Business review for the nine months ended September 30, 2018
Strong sales dynamic confirmed in third quarter, with an 8.8% increase in organic sales Growth of 9.8% at constant exchange rates and scope of consolidation over the nine months ended September 30: €1...
-
25 Sep 2018
bioMérieux commitments in the CDC’s “AMR Challenge”, a joint public-private sector initiative to accelerate the fight against antimicrobial resistance
Marcy l’Étoile (France) – Sept. 25, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, is participating in the AMR Challenge, a new Centers for Disease Control and Prevention (CDC...
-
05 Sep 2018
First-Half 2018 Results
Strong sales dynamic, with sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Contributive operating income before no...
-
18 Jul 2018
Second-Quarter 2018 Business Review
Strong sales dynamic confirmed in second quarter, leading to sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Growt...
-
12 Jun 2018
NEPHROCHECK® Biomarkers TIMP-2 and IGFBP7 Included in Acute Dialysis Quality Initiative Recommendations
The biomarkers in the NEPHROCHECK® test, an FDA-cleared and CE-marked urine test that indicates kidney stress in advance of acute kidney injury (AKI), have been included in a second set of consensus r...
-
31 May 2018
bioMérieux launches ENDOZYME® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in the bioMérieux ENDONEXTTM range of recombinant horseshoe...
-
02 May 2018
NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in Groundbreaking Consensus Statement of Best Practices to Enhance Recovery after Heart Surgery
Marcy l’Étoile (France) and San Diego (California) - May 2nd, 2018 – The biomarkers in the NEPHROCHECK test, an FDA-cleared and CE-marked urine test that indicates kidney stress in advance of acute ki...
-
23 Apr 2018
bioMérieux and the University of Antwerp award scholarships to three healthcare professionals for their commitment to improve antibiotic use in order to combat antimicrobial resistance
Marcy l'Étoile (France) – Antwerp (Belgium) – April 23, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp ...
-
19 Apr 2018
bioMérieux submits for FDA Clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel
bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clear...
-
19 Apr 2018
bioMérieux – First-Quarter 2018 Business Review
Strong sales dynamic in first-quarter 2018, with sales up 12.5% at constant exchange rates and scope of consolidation: €587 million in sales Up 3.4% as reported Growth driven by molecular biology in t...